Larsson C - Search Results

1

Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors.

Shi Y, Yuan J, Rraklli V, Maxymovitz E, Cipullo M, Liu M, Li S, Westerlund I, Bedoya-Reina OC, Bullova P, Rorbach J, Juhlin CC, Stenman A, Larsson C, Kogner P, O'Sullivan MJ, Schlisio S, Holmberg J. Shi Y, et al. Among authors: larsson c. Nucleic Acids Res. 2021 Mar 18;49(5):2509-2521. doi: 10.1093/nar/gkab054. Nucleic Acids Res. 2021. PMID: 33555349 Free PMC article.

2

Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.

Gray SG, Hartmann W, Eriksson T, Ekstrom C, Holm S, Kytola S, von Schweinitz D, Pietsch T, Larsson C, Kogner P, Sandstedt B, Ekstrom TJ. Gray SG, et al. Among authors: larsson c. Int J Mol Med. 2000 Aug;6(2):161-9. Int J Mol Med. 2000. PMID: 10891560

3

Loss of parafibromin expression in a subset of parathyroid adenomas.

Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, Weber G, Höög A, Villablanca A. Juhlin C, et al. Among authors: larsson c. Endocr Relat Cancer. 2006 Jun;13(2):509-23. doi: 10.1677/erc.1.01058. Endocr Relat Cancer. 2006. PMID: 16728578

4

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Höög A, Clark GJ, Ekström TJ, Bäckdahl M, Farnebo F, Larsson C. Geli J, et al. Among authors: larsson c, larsson o. Endocr Relat Cancer. 2007 Mar;14(1):125-34. doi: 10.1677/ERC-06-0031. Endocr Relat Cancer. 2007. PMID: 17395981

5

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.

Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenström J, Forsberg L, Bränström R, Obara T, Arnold A, Larsson C, Höög A. Juhlin CC, et al. Among authors: larsson c. Endocr Relat Cancer. 2007 Jun;14(2):501-12. doi: 10.1677/ERC-07-0021. Endocr Relat Cancer. 2007. PMID: 17639063

6

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

Geli J, Kogner P, Lanner F, Natalishvili N, Juhlin C, Kiss N, Clark GJ, Ekström TJ, Farnebo F, Larsson C. Geli J, et al. Among authors: larsson c. Int J Cancer. 2008 Jul 15;123(2):389-394. doi: 10.1002/ijc.23533. Int J Cancer. 2008. PMID: 18452173

7

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

Juhlin CC, Haglund F, Villablanca A, Forsberg L, Sandelin K, Bränström R, Larsson C, Höög A. Juhlin CC, et al. Among authors: larsson c. Int J Oncol. 2009 Feb;34(2):481-92. Int J Oncol. 2009. PMID: 19148484

8

Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.

Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, Larsson C. Juhlin CC, et al. Among authors: larsson c. PLoS One. 2010 Mar 1;5(3):e9472. doi: 10.1371/journal.pone.0009472. PLoS One. 2010. PMID: 20208994 Free PMC article.

9

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Juhlin CC, Nilsson IL, Johansson K, Haglund F, Villablanca A, Höög A, Larsson C. Juhlin CC, et al. Among authors: larsson c. Endocr Pathol. 2010 Sep;21(3):166-77. doi: 10.1007/s12022-010-9121-z. Endocr Pathol. 2010. PMID: 20473645

10

Suppression of RIZ in biologically unfavourable neuroblastomas.

Geli J, Kiss N, Kogner P, Larsson C. Geli J, et al. Among authors: larsson c. Int J Oncol. 2010 Nov;37(5):1323-30. doi: 10.3892/ijo_00000784. Int J Oncol. 2010. PMID: 20878080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,092 results

Search Page

Filters